HIV. “Trattamento con cabotegravir + rilpivirina ha dimostrato un'efficacia superiore nel ...
|
I dati finali dello studio di fase III Latitude confermano
che il trattamento iniettabile long acting per l'HIV cabotegravir +
rilpivirina ha ... |
Italiano — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.